Literature DB >> 22072188

Scavenger receptor expressions in the kidneys of mice with lipoprotein glomerulopathy.

Yoshiro Miyahara1, Shinsuke Nishimura, Maho Watanabe, Kenji Ito, Hitoshi Nakashima, Takao Saito.   

Abstract

BACKGROUND: To clarify whether dysfunction of the scavenger receptor (SR) participates in the development of lipoprotein glomerulopathy (LPG) in immunoglobulin F(c) receptor γ chain (F(c)Rγ)-deficient mice [F(c)Rγ knock-out (KO) mice] with induced chronic graft-versus-host disease (cGVHD).
METHOD: In wild-type (WT) and F(c)Rγ KO C57BL/6 mice, cGVHD was induced by injection of lymphoid cells from donor Bm12 mice. At 6 months after injection, the mice were sacrificed and histologically examined. Total RNA was extracted from the kidneys and cytokine, chemokine, and SR transcript expressions were evaluated by reverse transcription-polymerase chain reaction.
RESULTS: Three of 4 female cGVHD(+)/F(c)Rγ KO mice presented LPG in >60% of glomeruli. cGVHD(-) and cGVHD(+)/WT mice did not show LPG. The SRs CD36, CD68, and CXCL16 showed a significant difference in the values of their transcripts between cGVHD(+)/WT and cGVHD(+)/F(c)Rγ KO mice. Among them, only CD36 showed a drastic decline of mRNA expressions in cGVHD(+)/F(c)Rγ KO mice.
CONCLUSION: CD36 may play a crucial role in the development of LPG in F(c)Rγ KO mice with cGVHD. In addition to the apolipoprotein E mutation, dysfunction of lipid clearance in the kidney might be one of the factors for the development of LPG.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22072188     DOI: 10.1007/s10157-011-0554-6

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  32 in total

1.  A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein.

Authors:  L W Stanton; R T White; C M Bryant; A A Protter; G Endemann
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

2.  Differential effects of interferon-gamma on metabolism of lipoprotein immune complexes mediated by specific human macrophage Fcgamma receptors.

Authors:  P M Morganelli; S M Kennedy; T I Mitchell
Journal:  J Lipid Res       Date:  2000-03       Impact factor: 5.922

Review 3.  Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.

Authors:  Takao Saito; Akira Matsunaga; Shinichi Oikawa
Journal:  Am J Kidney Dis       Date:  2006-02       Impact factor: 8.860

4.  Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL.

Authors:  D Calvo; D Gómez-Coronado; Y Suárez; M A Lasunción; M A Vega
Journal:  J Lipid Res       Date:  1998-04       Impact factor: 5.922

Review 5.  Divergent roles for Fc receptors and complement in vivo.

Authors:  J V Ravetch; R A Clynes
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

6.  Identification of low density lipoprotein as a regulator of Fc receptor-mediated phagocytosis.

Authors:  R D Bigler; M Khoo; S Lund-Katz; L Scerbo; M Esfahani
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

7.  Genetic factors influencing the development of chronic graft-versus-host disease in a murine model.

Authors:  D L Slayback; J A Dobkins; J M Harper; R D Allen
Journal:  Bone Marrow Transplant       Date:  2000-11       Impact factor: 5.483

8.  Apolipoprotein E2/E5 variants in lipoprotein glomerulopathy recurred in transplanted kidney.

Authors:  T Miyata; S Sugiyama; M Nangaku; D Suzuki; K Uragami; R Inagi; H Sakai; K Kurokawa
Journal:  J Am Soc Nephrol       Date:  1999-07       Impact factor: 10.121

9.  Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy.

Authors:  S Oikawa; N Suzuki; E Sakuma; T Saito; K Namai; H Kotake; Y Fujii; T Toyota
Journal:  Am J Kidney Dis       Date:  1991-11       Impact factor: 8.860

10.  Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation.

Authors:  R L Griffith; G T Virella; H C Stevenson; M F Lopes-Virella
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Topics in lipoprotein glomerulopathy: an overview.

Authors:  Takao Saito; Akira Matsunaga; Kenji Ito; Hitoshi Nakashima
Journal:  Clin Exp Nephrol       Date:  2013-10-23       Impact factor: 2.801

2.  CD36 and Na/K-ATPase-α1 form a proinflammatory signaling loop in kidney.

Authors:  David J Kennedy; Yiliang Chen; Wenxin Huang; Jamie Viterna; Jiang Liu; Kristen Westfall; Jian Tian; David J Bartlett; W H Wilson Tang; Zijian Xie; Joseph I Shapiro; Roy L Silverstein
Journal:  Hypertension       Date:  2012-11-19       Impact factor: 10.190

3.  Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations.

Authors:  Mingxin Yang; Qinjie Weng; Xiaoxia Pan; Hafiz Muhammad Jafar Hussain; Shuwen Yu; Jing Xu; Xialian Yu; Yunzi Liu; Yuanmeng Jin; Chunli Zhang; Xiao Li; Hong Ren; Nan Chen; Jingyuan Xie
Journal:  Mol Genet Genomic Med       Date:  2020-05-22       Impact factor: 2.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.